Blog
RSS FeedPosted by Michael Wonder on 14 Feb 2019
OIA responses: exploring ways to publish them
14 February 2019 - To support New Zealand's commitment to open government, PHARMAC is exploring ways to publish more of ...
Posted by Michael Wonder on 23 Jan 2019
Trump plan to force drug makers to advertise prices might work, but not if pharma gets its way
23 January 2019 - Trump administration proposal to require drug makers to advertise prices in television ads could dissuade consumers ...
Posted by Michael Wonder on 23 Jan 2019
Trump's drug ad price transparency contains huge loophole, researchers identify
22 January 2019 - The Trump administration's proposal to require pharmaceutical companies to list drug prices in television ads would ...
Posted by Michael Wonder on 18 Jan 2019
2019 April price disclosure cycle – indicative prices
18 January 2019 - Indicative 1 April 2019 prices resulting from the 2019 April cycle of price disclosure have now been ...
Posted by Michael Wonder on 08 Jan 2019
Drug maker won't put price in TV ads, but patients can look it up
8 January 2019 - Eli Lilly will tout website in spots for biggest diabetes drug. ...
Posted by Michael Wonder on 15 Dec 2018
Price disclosure 2019 April cycle outcomes summary
14 December 2018 - The summary of price disclosure price reductions for the 2019 April Cycle has now been published. ...
Posted by Michael Wonder on 15 Nov 2018
Disclosing prescription-drug prices in advertisements — legal and public health issues
14 November 2018 - On October 15, 2018, the CMS proposed a rule requiring television advertisements for prescription drugs and ...
Posted by Michael Wonder on 12 Nov 2018
Drug prices on ads: as ‘relevant’ as percent daily value on food labels
9 November 2018 - President Trump announced late last month that his administration will push back on high drug costs ...
Posted by Michael Wonder on 25 Oct 2018
Pharmaceutical industry challenges Trump plan forcing companies to reveal drug prices in TV ads
25 October 2018 - Symbicort, an inhaler marketed to people whose lung disease makes them “huff and puff,” rolls off ...
Posted by Michael Wonder on 23 Oct 2018
Drug prices in advertisements actually hurt consumers
23 October 2018 - This month, the Trump administration proposed a new rule that would require advertisements for prescription drugs ...
Posted by Michael Wonder on 22 Oct 2018
Trump and his team fight for health consumers, starting with drug price transparency
22 October 2018 - Drugs like EpiPen have exorbitant prices due to price gouging. The Trump administration is taking steps to ...
Posted by Michael Wonder on 16 Oct 2018
Drug price transparency won’t end the patent games
17 October 2018 - Just look at Humira, which is keeping its U.S. monopoly as generics hit the European market. ...
Posted by Michael Wonder on 16 Oct 2018
CMS proposes to require manufacturers to disclose drug prices in television ads
15 October 2018 - Proposed rule would further the Trump Administration’s commitment to lower prescription drug prices by requiring companies ...
Posted by Michael Wonder on 10 Oct 2018
Why it's not so simple to standardise the guides insurers use to pay for off-label cancer drugs
10 October 2018 - In accordance with federal law, CMS must reimburse cancer drugs used off-label if one of five ...
Posted by Michael Wonder on 10 Oct 2018
Trump signs bills aimed at increasing drug price transparency
10 October 2018 - President Donald Trump signed two pieces of legislation into law on Wednesday that aim to inform ...